CD8A and Autoimmunity: Targeting circulatory helper CD8+ T cells might offer a perspective to reduce systemic effects of autoimmunity and allergic disorders, such as autoantibody formation or the migration of cells to induce inflammation at barrier sites (skin and lung), which needs to be further examined.